Techno Drugs Ltd.

DSE:TECHNODRUG Stock Report

Market Cap: ৳4.5b

Techno Drugs Valuation

Is TECHNODRUG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of TECHNODRUG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: TECHNODRUG (BDT34.8) is trading above our estimate of fair value (BDT2.51)

Significantly Below Fair Value: TECHNODRUG is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for TECHNODRUG?

Key metric: As TECHNODRUG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for TECHNODRUG. This is calculated by dividing TECHNODRUG's market cap by their current earnings.
What is TECHNODRUG's PE Ratio?
PE Ratio23.2x
Earnings৳195.51m
Market Cap৳4.54b

Price to Earnings Ratio vs Peers

How does TECHNODRUG's PE Ratio compare to its peers?

The above table shows the PE ratio for TECHNODRUG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average55.7x
NAVANAPHAR Navana Pharmaceuticals
13.7xn/a৳5.5b
ORIONINFU Orion Infusion
150.4xn/a৳6.4b
IBNSINA IBN SINA Pharmaceutical Industry
14.6x25.5%৳8.7b
ORIONPHARM Orion Pharma
44xn/a৳8.7b
TECHNODRUG Techno Drugs
23.2xn/a৳4.5b

Price-To-Earnings vs Peers: TECHNODRUG is good value based on its Price-To-Earnings Ratio (23.2x) compared to the peer average (55.7x).

Price to Earnings Ratio vs Industry

How does TECHNODRUG's PE Ratio compare vs other companies in the Asian Pharmaceuticals Industry?

12 CompaniesPrice / EarningsEstimated GrowthMarket Cap
TECHNODRUG 23.2xIndustry Avg. 24.6xNo. of Companies74PE020406080100+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: TECHNODRUG is good value based on its Price-To-Earnings Ratio (23.2x) compared to the Asian Pharmaceuticals industry average (24.7x).

Price to Earnings Ratio vs Fair Ratio

What is TECHNODRUG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TECHNODRUG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate TECHNODRUG's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies